Tumor microenvironment and progression of pancreatic cancer.
about
Recent progress in pancreatic cancerMolecular imaging in pancreatic cancer--a roadmap for therapeutic decisions.The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathwaysInvolvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice.Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma.Metformin suppresses pancreatic tumor growth with inhibition of NFκB/STAT3 inflammatory signaling.Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle.Tie1 deficiency induces endothelial-mesenchymal transition.Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinomaSelective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer.Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer.How fibrosis influences imaging and surgical decisions in pancreatic cancer.CXCL12/CXCR4 protein signaling axis induces sonic hedgehog expression in pancreatic cancer cells via extracellular regulated kinase- and Akt kinase-mediated activation of nuclear factor κB: implications for bidirectional tumor-stromal interactions.Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase.Changes in connexin43 expression and localization during pancreatic cancer progressionMetastatic pancreatic cancer: are we making progress in treatment?Oncogenic transcription factors: cornerstones of inflammation-linked pancreatic carcinogenesisIontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinomaA preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer TherapeuticsExtracellular DNA in pancreatic cancer promotes cell invasion and metastasis.Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers.Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.Role of pancreatic stellate cells in chemoresistance in pancreatic cancer.ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.Cellular and molecular aspects of pancreatic cancer.Proteome variations in pancreatic stellate cells upon stimulation with proinflammatory factors.Mesenchymal stromal cells protect cancer cells from ROS-induced apoptosis and enhance the Warburg effect by secreting STC1Nerve-cancer interactions in the stromal biology of pancreatic cancer.Tumor-exosomes and leukocyte activation: an ambivalent crosstalkGeneration of an in vitro 3D PDAC stroma rich spheroid model.PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway.
P2860
Q24626346-75443F10-A99B-4A87-B2F5-327915207F71Q30423854-A707B664-470E-4628-B900-A26852139A01Q34185812-8F83A1DA-340B-4A81-A275-D56720775D71Q34359125-67A47A7D-4B3B-4F3D-865C-6CD8C37CA2F6Q34385867-59235E4C-ACC5-49BA-BDD7-14BC356FE04BQ35439302-7172D381-8783-4766-B3EB-37FFFDAE0CDEQ35487646-00FC0107-33BD-4E2B-B7B3-FD08A0B585ADQ35537413-E72CAF14-02B1-4354-85A9-2803500F871AQ35931790-7E30BF4D-3DFC-4366-B4E8-62FDAB8F762EQ36124027-EF3FCF0F-7B42-4CEF-96E2-FB856ADF0125Q36140625-F1C65D53-D1AF-4C08-8F28-B8D6C7A00EC8Q36177354-FA44AD90-E7B4-42AB-AC5A-8A8D97BB3FD0Q36291856-984437EE-9595-49CE-80FF-BB9EF1297167Q36385974-FA94B117-F2FE-4AD9-B7EF-CDA7252D9A69Q36446801-E4A20DE7-ACE4-4350-8AEF-6895CA89F340Q36456187-BDFC87BF-43D1-4C0E-BA32-803902982F69Q36469038-7FDE2218-C539-4E54-AA0A-300D80A5C664Q36516948-E7614321-EED7-4A40-9C9D-365D80653F34Q36646313-26843010-2E26-4190-BE4D-E28E851EE5CBQ36851289-564A20DA-53B3-4482-8160-79465EA076E9Q36918125-7689765F-110D-46D2-9C1C-CA6C5858CDC9Q37184055-8F36C666-555F-4F4F-9B47-1CD56EAD592EQ37187922-386C49DB-69ED-4D41-BB3E-27EAF0CA5DCEQ37697130-36C15E6A-8026-483A-8F10-76A74381176BQ37705462-A1B1E875-6B50-49BE-A674-31C05384654DQ38729111-076B398B-B78C-48CA-A6E2-159EE06701C7Q38730160-EFED0EBB-7902-4AFB-A4AA-8A150BD335E2Q39088558-4AED009F-BE81-4F8A-A806-34D525D602B5Q41020605-C8FB6898-4228-4CF2-B9D1-768A4144B90DQ41953936-A7CDC230-6518-44E4-ABDC-EF61868A2ED2Q42406891-882079E8-6B66-4D9C-9DD1-02921FF61EEDQ42678442-C4803726-7456-47B7-97DA-F73DBC8C1039Q46331963-84D826E2-C05B-4CE3-9155-A8E3CFA1544D
P2860
Tumor microenvironment and progression of pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor microenvironment and progression of pancreatic cancer.
@en
Tumor microenvironment and progression of pancreatic cancer.
@nl
type
label
Tumor microenvironment and progression of pancreatic cancer.
@en
Tumor microenvironment and progression of pancreatic cancer.
@nl
prefLabel
Tumor microenvironment and progression of pancreatic cancer.
@en
Tumor microenvironment and progression of pancreatic cancer.
@nl
P2093
P1476
Tumor microenvironment and progression of pancreatic cancer
@en
P2093
Michalski CW
Reiser-Erkan C
P304
P50
P577
2010-09-01T00:00:00Z